Basic Information
NeuroRx, Inc. is a clinical-stage pharmaceutical company developing NRX-101, the first oral therapy for the treatment of Acute Suicidal Ideation/Behavior (ASIB) in bipolar depression.
NeuroRx, Inc.
Wilmington,Delaware,United States of America
less than 15 people
January 01, 2015
nrxsocial@neurorxpharma.com